logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10800772 B1

PDFFull Text
Date of Patent:
Oct. 13, 2020

Filed:

Sep. 26, 2017

Therapeutic compounds

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Zhenhong R. Cai, Palo Alto, CA (US);

Hongyan Guo, San Mateo, CA (US);

Mingzhe Ji, Union City, CA (US);

Haolun Jin, Foster City, CA (US);

Amy Lee, Palo Alto, CA (US);

Ryan McFadden, Foster City, CA (US);

Michael L. Mitchell, Castro Valley, CA (US);

Manuel Munoz, Vallejo, CA (US);

Hyung-Jung Pyun, Fremont, CA (US);

Lianhong Xu, Palo Alto, CA (US);

Hong Yang, Fremont, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:
Primary Examiner:

Shawquia Jackson

Int. Cl.
CPC ...
C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 417/14 (2006.01); A61P 31/18 (2006.01); A61K 31/428 (2006.01); A61K 31/439 (2006.01); A61K 31/454 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/5383 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); C07D 471/08 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01); C07D 491/107 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/428 (2013.01); A61K 31/439 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 31/55 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); A61P 31/18 (2018.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 471/08 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 491/107 (2013.01); C07D 498/04 (2013.01);
Abstract

Compounds disclosed herein including compounds of Formula I: and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.

Find Patent Forward Citations

Loading…